# This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

> **NCT03258645** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1489 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dabigatran

## Key facts

- **NCT ID:** NCT03258645
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-15
- **Primary completion:** 2019-06-17
- **Final completion:** 2019-06-17
- **Target enrollment:** 1489 (ACTUAL)
- **Last updated:** 2020-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258645, "This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03258645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*